294 related articles for article (PubMed ID: 9572002)
21. The two extremes of cardiac sarcoidosis and the effect of Prednisone therapy.
Armstrong D; Gonzalez-Stawinski GV; Ko JM; Hall SA; Roberts WC
Am J Cardiol; 2015 Jan; 115(1):150-3. PubMed ID: 25456861
[TBL] [Abstract][Full Text] [Related]
22. [Sarcoidosis in children. Clinical manifestations, epidemiology, treatment and prognosis].
Hoffmann AL; Milman N
Ugeskr Laeger; 1996 Mar; 158(12):1657-61. PubMed ID: 8644407
[TBL] [Abstract][Full Text] [Related]
23. The Circulating Treg/Th17 Cell Ratio Is Correlated with Relapse and Treatment Response in Pulmonary Sarcoidosis Patients after Corticosteroid Withdrawal.
Liu Y; Qiu L; Wang Y; Aimurola H; Zhao Y; Li S; Xu Z
PLoS One; 2016; 11(2):e0148207. PubMed ID: 26845566
[TBL] [Abstract][Full Text] [Related]
24. [Recurrence of pulmonary sarcoidosis].
Puścińska E; Zych D; Pawlicka L; Zieliński J
Pneumonol Alergol Pol; 1995; 63(7-8):389-92. PubMed ID: 8520555
[TBL] [Abstract][Full Text] [Related]
25. Renal sarcoidosis: epidemiological and follow-up data in a cohort of 27 patients.
Löffler C; Löffler U; Tuleweit A; Waldherr R; Uppenkamp M; Bergner R
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):306-15. PubMed ID: 25591142
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of the treatment and prognosis of 59 patients with sarcoidosis].
Ding K; Xu ZJ; Huang H; Lu WX; Luo WC
Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):52-5. PubMed ID: 17331391
[TBL] [Abstract][Full Text] [Related]
27. Clinical aspects of pulmonary sarcoidosis.
Judson MA
J S C Med Assoc; 2000 Jan; 96(1):9-17. PubMed ID: 10670174
[TBL] [Abstract][Full Text] [Related]
28. Upper Airway Obstruction Requiring Emergent Tracheostomy Secondary to Laryngeal Sarcoidosis: A Case Report.
Ryu C; Herzog EL; Pan H; Homer R; Gulati M
Am J Case Rep; 2017 Feb; 18():157-159. PubMed ID: 28190872
[TBL] [Abstract][Full Text] [Related]
29. The clinical spectrum of the sarcoid peripheral lymph node.
Rizzato G; Montemurro L
Sarcoidosis Vasc Diffuse Lung Dis; 2000 Mar; 17(1):71-80. PubMed ID: 10746264
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: A single center real-world study.
Fang C; Zhang Q; Wang N; Jing X; Xu Z
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):217-227. PubMed ID: 32476957
[TBL] [Abstract][Full Text] [Related]
31. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients.
Baughman RP; Barney JB; O'Hare L; Lower EE
Respir Med; 2016 Jan; 110():66-72. PubMed ID: 26626451
[TBL] [Abstract][Full Text] [Related]
32. Outcome of the treatment for sarcoidosis.
Hunninghake GW; Gilbert S; Pueringer R; Dayton C; Floerchinger C; Helmers R; Merchant R; Wilson J; Galvin J; Schwartz D
Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):893-8. PubMed ID: 8143052
[TBL] [Abstract][Full Text] [Related]
33. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of the efficiency of various treatment regimens for patients with newly-detected sarcoidosis in the Republic of Tatarstan].
Vizel' AA; Nasretdinova GR; Islamova LV; Vizel' EA
Probl Tuberk Bolezn Legk; 2006; (4):19-23. PubMed ID: 16813054
[TBL] [Abstract][Full Text] [Related]
35. Recovery of adrenocortical function during long-term treatment with corticosteroids.
Westerhof L; van Ditmars MJ; Kinderen PJ der ; Thijssen JH; Schwarz F
Br Med J; 1970 Nov; 4(5734):534-7. PubMed ID: 4321238
[TBL] [Abstract][Full Text] [Related]
36. Increased proportions of circulating PD-1
Miedema JR; de Jong LJ; Kahlmann V; Bergen IM; Broos CE; Wijsenbeek MS; Hendriks RW; Corneth OBJ
Respir Res; 2024 May; 25(1):196. PubMed ID: 38715030
[TBL] [Abstract][Full Text] [Related]
37. Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis.
Alba MA; García-Martínez A; Prieto-González S; Espígol-Frigolé G; Butjosa M; Tavera-Bahillo I; Rodríguez-Pintó I; Hernández-Rodríguez J; Cid MC
Semin Arthritis Rheum; 2014 Jun; 43(6):772-7. PubMed ID: 24315461
[TBL] [Abstract][Full Text] [Related]
38. Comparison of outcomes in patients with probable versus definite cardiac sarcoidosis.
Takaya Y; Kusano KF; Nakamura K; Ito H
Am J Cardiol; 2015 May; 115(9):1293-7. PubMed ID: 25743209
[TBL] [Abstract][Full Text] [Related]
39. [Pulmonary and cardiac recurrence of sarcoidosis in a heart transplant recipient].
Strecker T; Zimmermann I; Wiest GH
Dtsch Med Wochenschr; 2007 May; 132(21):1159-62. PubMed ID: 17506010
[TBL] [Abstract][Full Text] [Related]
40. No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis.
Broos CE; Poell LHC; Looman CWN; In 't Veen JCCM; Grootenboers MJJH; Heller R; van den Toorn LM; Wapenaar M; Hoogsteden HC; Kool M; Wijsenbeek MS; van den Blink B
Respir Med; 2018 May; 138S():S31-S37. PubMed ID: 29137908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
